Orthofix Medical, Inc. reported $203.121 million in sales and ($16,003) million in operating losses for the quarter ending ...

Few debates in knee arthroplasty spark as much polite-but-pointed hallway chatter as the fixation question: cemented or ...

The champagne corks are probably still rolling around at Cerapedics HQ. In June 2025, the company secured FDA premarket approval for its PearlMatrix™ P-15 Peptide Enhanced Bone Graft — and now they’ve ...

In spine surgery, measuring success isn’t always as simple as “X-rays look straighter, job well done.” Deformity surgeons ...

In sports medicine, the holy grail for anterior cruciate ligament reconstruction (ACLR) is simple: less pain, faster recovery ...

Integra LifeSciences Holdings Corporation reported $415.6 million in sales and ($512.674) million in operating losses for the ...

CONMED’s 2Q25 numbers are in, and the picture is a mix of solid topline growth, orthopedic momentum, and some capital-market ...

Stryker Corporation is in growth mode—again. In its Q2 2025 earnings call, CEO Kevin Lobo and VP of Finance and Investor ...

A new systematic review and meta-analysis in The Journal of Bone and Joint Surgery (July 29, 2025) is asking a question that ...

It's time to stop casually watching Alphatec Holdings, Inc. and start paying attention—they're not just growing, they’re ...

According to a new meta-analysis in the July 13, 2025, Journal of Experimental Orthopaedics, you’ll need to perform somewhere ...